FDA DrugClass INotable

FDA Recall: Cetirizine Hydrochloride Tablets USP 5 mg, 100-count bottle, Manufactured by: Unique Pharmaceuticals

Date: 2026-07-29
Brand: JB Chemicals and Pharmaceuticals Ltd
Category: Drug
FDA Class: Class I

Description

Cross Contamination with Other Products: Customer complaints for appearance of discolored tablets and red dots observed on Cetirizine Hydrochloride Tablets USP 5 mg. Determined to be Ranitidine.

Hazard

Cross Contamination with Other Products: Customer complaints for appearance of discolored tablets and red dots observed on Cetirizine Hydrochloride Tablets USP 5 mg. Determined to be Ranitidine.

Remedy

34,020 100-count bottles.

View original recall →
Share:

Related Recalls

2026-08-05 · FDA_DRUG
FDA Recall: Dabigatran Etexilate Capsules, 75 mg, 30-count (3x10) blister pack, Rx only, Manufactured by: Alkem
Ascend Laboratories, LLC
2026-08-05 · FDA_DRUG
FDA Recall: Azelaic Acid Gel, 15%, 50 gram tubes, For Topical Use only, Rx only, Distributed by: Glenmark Pharma
Glenmark Pharmaceuticals Inc., USA
2026-08-05 · FDA_DRUG
FDA Recall: Dorzolamide HCl and Timolol Maleate Ophthalmic Solution, USP, 2%/0.5%, 10mL - bottle, Rx only, Manuf
MICRO LABS USA INC
2026-08-05 · FDA_DRUG
FDA Recall: Mycophenolate Mofetil for Injection USP, 500 mg/Vial, Single Dose Vial, 4 vials per carton, Rx only,
MYLAN PHARMACEUTICALS INC